Coya Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DME CAPITAL MANAGEMENT, LP | 05/15/2025 | 1.65 M | $10.65 M | 0.00% | 9.85% |
AIGH CAPITAL MANAGEMENT LLC | 05/06/2025 | 1.18 M | $7.66 M | -1.45% | 7.08% |
VANGUARD GROUP INC | 05/09/2025 | 840.47 K | $5.44 M | 0.00% | 5.03% |
CM MANAGEMENT, LLC | 05/09/2025 | 200.00 K | $1.29 M | 25.00% | 1.20% |
05/07/2025 | 167.38 K | $1.08 M | 100.00% | 1.00% | |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 155.83 K | $1.01 M | 3.49% | 0.93% |
BLACKROCK, INC. | 05/02/2025 | 83.80 K | $542.15 K | 9.98% | 0.50% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 58.98 K | $381.61 K | 91.91% | 0.35% |
STATE STREET CORP | 05/15/2025 | 48.10 K | $311.21 K | 0.00% | 0.29% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 35.77 K | $231.43 K | 0.00% | 0.21% |
UBS GROUP AG | 05/13/2025 | 34.09 K | $220.56 K | -20.77% | 0.20% |
CITADEL ADVISORS LLC | 05/15/2025 | 33.94 K | $219.62 K | 100.00% | 0.20% |
NORTHERN TRUST CORP | 05/13/2025 | 31.18 K | $201.73 K | 9.21% | 0.19% |
GHP INVESTMENT ADVISORS, INC. | 04/23/2025 | 26.17 K | $169.33 K | 0.00% | 0.16% |
JANE STREET GROUP, LLC | 05/19/2025 | 26.14 K | $169.11 K | 101.66% | 0.16% |
ROYAL BANK OF CANADA | 05/15/2025 | 20.65 K | $134.00 K | -8.83% | 0.12% |
ATOM INVESTORS LP | 05/15/2025 | 19.73 K | $127.62 K | 38.17% | 0.12% |
PROSPERITY WEALTH MANAGEMENT, INC. | 04/18/2025 | 16.05 K | $103.84 K | 100.00% | 0.10% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 12.20 K | $78.93 K | 100.00% | 0.07% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 10.00 K | $64.70 K | 100.00% | 0.06% |
MORGAN STANLEY | 05/15/2025 | 6.74 K | $43.61 K | 140.71% | 0.04% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 3.34 K | $21.62 K | 0.00% | 0.02% |
05/02/2025 | 911 | $5.89 K | 19.71% | 0.01% | |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/13/2025 | 500 | $3.24 K | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 285 | $1.84 K | -94.57% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 121 | $783 | 5.22% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 0 | $0 | -100.00% | 0.00% |
MIRADOR CAPITAL PARTNERS LP | 04/09/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Coya Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Coya Therapeutics, Inc.. The most heavily invested institutionals were:
DME Capital Management, LP: 1.65 M
AIGH Capital Management LLC: 1.18 M
VANGUARD GROUP INC: 840,471
CM Management, LLC: 200,000
GEODE CAPITAL MANAGEMENT, LLC: 155,829
BlackRock, Inc.: 83,795
27.89% of Coya Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.85 M shares in the last 24 months. This purchase volume represents approximately $33.31 M in transactions.